Besponsa
| Besponsa | |
|---|---|
| Term | Besponsa |
| Short definition | Besponsa - (pronounced) (beh-SPON-suh) A drug used to treat adults with B-cell acute lymphoblastic leukemia that has come back or has not improved with other treatments. It is also being studied in the treatment of other types of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Besponsa - (pronounced) (beh-SPON-suh) A drug used to treat adults with B-cell acute lymphoblastic leukemia that has come back or has not improved with other treatments. It is also being studied in the treatment of other types of cancer. Besponsa contains a monoclonal antibody that attaches to a protein called CD22, which is found on some leukemia cells. It also contains a cancer drug that can help kill cancer cells. Besponsa is a type of antibody-drug conjugate. Also called inotuzumab ozogamicin
External links
- Medical encyclopedia article on Besponsa
- Wikipedia's article - Besponsa
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski